Vascular Biogenics Ltd (NASDAQ:VBLT)

Delayed Data
As of Sep 22
 +0.0011 / +0.52%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Vascular Biogenics Ltd have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +2,264.07% increase from the last price of 0.21.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Hold stock in Vascular Biogenics Ltd. This rating has held steady since November, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -16.67%
Growthannually -42.86%


Growthquarterly 0.00%
Growthannually 171.43%
Key to the earnings and sales forecast charts.